Skip to main content
. 2023 Apr 17;270(8):3770–3778. doi: 10.1007/s00415-023-11714-1

Table 2.

HCRUa and costsb in PwPSP and matched MHS members without PSP during the year prior index date

N with event Crude estimated mean Adjusted estimated meanc
PSP
n = 88
No PSP
n = 264
p value crude p value adjusted PSP No PSP p value PSP No PSP p value
Hospitalization days 36 (40.9%) 42 (15.9%)  < 0.001  < 0.001 HCRU 10.1 (7.3–13.9) 10.9 (7.4–16.1) 0.746 10 (5.7–17.5) 11.9 (5.5–25.6) 0.529
Costs 8312 (6073–11,377) 6576 (4710–9180)  < 0.001 7371 (4492–12,096) 6438 (3149–13,163) 0.592
ED visits 34 (38.6%) 36 (13.6%)  < 0.001  < 0.001 HCRU 1.5 (1.3–1.7) 1.4 (1.2–1.6) 0.629 1.2 (1–1.6) 1.1 (0.8–1.3) 0.192
Costs 314 (277–356) 301 (268–337) 0.612 332 (283–389) 287 (232–356) 0.097
Outpatients visits 88 (100.0%) 250 (94.7%) 0.997 0.996 HCRU 45.5 (40.5–51.1) 24.3 (21.9–27.1)  < 0.001 48.8 (41.2–57.8) 26.1 (21–32.4)  < 0.001
Costs 3205 (2866–3584) 1746 (1585–1922)  < 0.001 3267 (2791–3825) 1737 (1426–2116)  < 0.001
Treatment and procedures 83 (94.3%) 221 (83.7%) 0.017 0.051 HCRU 6 (5.1–7.1) 7.4 (5.4–10.1) 0.259 6.5 (4.7–8.9) 7.1 (4.7–10.7) 0.568
Costs 1561 (1089–2238) 962 (796–1163) 0.020 1730 (965–3099) 957 (495–1848) 0.006
Medications 86 (97.7%) 243 (92.0%) 0.080 0.274 HCRU 112.6 (98.4–128.8) 79.6 (71.3–88.8)  < 0.001 104.8 (85.4–128.7) 70.8 (55.1–91)  < 0.001
Costs 1262 (1063–1498) 848 (736–977)  < 0.001 1105 (858–1422) 722 (537–972)  < 0.001
Overall direct costs Costs 9449 (7926–11,263) 4881 (4163–5722)  < 0.001 9128 (6994–11,914) 4316 (3214–5796)  < 0.001

Estimated means, 95% CI, and p value were extracted from GEE with negative binomial distribution with log link for HCRU analyses and gamma distribution with log-link function for costs analyses

PwPSP patients with progressive supranuclear palsy, HCRU healthcare resource utilization, ED emergency department, CI confidence interval, GEE generalized estimating equations

aPresented data were calculated for patients with ≥ 1 HCRU

bTop 1% was excluded

cAnalyses were adjusted for age, sex, socioeconomic status, chronic kidney disease, dementia, and mild cognitive impairment